The Role of Tyrosine Kinases as a Critical Prognostic Parameter and Its Targeted Therapies in Ewing Sarcoma
- Authors
- Jin, W.
- Issue Date
- Jul-2020
- Publisher
- Frontiers Media S.A.
- Keywords
- acquisition of self-renewal traits; aggressiveness; chemoresistance; clinical pathogenesis; Ewing sarcoma; therapeutic target; tyrosine kinases
- Citation
- Frontiers in Cell and Developmental Biology, v.8
- Journal Title
- Frontiers in Cell and Developmental Biology
- Volume
- 8
- URI
- https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/77999
- DOI
- 10.3389/fcell.2020.00613
- ISSN
- 2296-634X
- Abstract
- Ewing sarcoma (ES) is a rare, highly aggressive, bone, or soft tissue-associated tumor. Although this sarcoma often responds well to initial chemotherapy, 40% of the patients develop a lethal recurrence of the disease, with death recorded in 75–80% of patients with metastatic ES within 5 years, despite receiving high-dose chemotherapy. ES is genetically well-characterized, as indicated by the EWS-FLI1 fusion protein encoded as a result of chromosomal translocation in 80–90% of patients with ES, as well as in ES-related cancer cell lines. Recently, tyrosine kinases have been identified in the pathogenesis of ES. These tyrosine kinases, acting as oncoproteins, are associated with the clinical pathogenesis, metastasis, acquisition of self-renewal traits, and chemoresistance of ES, through the activation of various intracellular signaling pathways. This review describes the recent progress related to cellular and molecular functional roles of tyrosine kinases in the progression of ES. © Copyright © 2020 Jin.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - 의과대학 > 의예과 > 1. Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/77999)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.